Talphera (TLPH) Enterprise Value (2010 - 2026)
Talphera (TLPH) posted quarterly Enterprise Value of -$37.8 million for Q1 2026, down 602.12% year-over-year from $7.5 million in Q1 2025, and down 9.8% quarter-over-quarter from -$34.5 million in Q4 2025.
Talphera (TLPH) Enterprise Value (2010 - 2026) Analysis & Trends
Talphera's Enterprise Value history runs 17 years deep, the most recent figure standing at -$37.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 602.12% year-over-year to -$37.8 million; the TTM figure through Mar 2026 stood at -$37.8 million (down 602.12% YoY), while the FY2025 annual figure was -$34.5 million, down 288.74% from the prior year.
- Enterprise Value for Q1 2026 stood at -$37.8 million, down from -$34.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$4.8 million in Q2 2023, with the low at -$56.8 million in Q1 2022.
- The 5-year median for Enterprise Value is -$14.0 million (2024), against an average of -$19.5 million.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value surged 79.52% in 2023, then slumped 602.12% in 2026.
- Talphera's Enterprise Value stood at -$15.8 million in 2022, then gained by 17.31% to -$13.0 million in 2023, then jumped by 32.04% to -$8.9 million in 2024, then plunged by 288.74% to -$34.5 million in 2025, then declined by 9.8% to -$37.8 million in 2026.
- Business Quant data shows TLPH's Enterprise Value at -$37.8 million in Q1 2026, -$34.5 million in Q4 2025, and -$38.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | Talphera | 89.88 Mn | 89.88 Mn | - | -33.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.41 Mn |
| Mar 31, 2026 | -37.83 Mn |
| Dec 31, 2025 | -34.45 Mn |
| Sep 30, 2025 | -38.86 Mn |
| Jun 30, 2025 | -6.18 Mn |
| Mar 31, 2025 | -5.39 Mn |
| Dec 31, 2024 | -8.86 Mn |
| Sep 30, 2024 | -11.12 Mn |
| Jun 30, 2024 | -14.02 Mn |
| Mar 31, 2024 | -25.05 Mn |
| Dec 31, 2023 | -13.04 Mn |
| Sep 30, 2023 | -11.73 Mn |
| Jun 30, 2023 | -4.77 Mn |
| Mar 31, 2023 | -11.64 Mn |
| Dec 31, 2022 | -15.77 Mn |
| Sep 30, 2022 | -15.93 Mn |
| Jun 30, 2022 | -20.17 Mn |
| Mar 31, 2022 | -56.83 Mn |
| Dec 31, 2021 | -51.63 Mn |
| Sep 30, 2021 | -43.70 Mn |